Loading...
Market
Will a major pharmaceutical company adopt the ClpX unfoldase and CsgG nanopore protein reading technique by end of 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Official press releases or announcements from major pharmaceutical companies
Story
Groundbreaking Single-Molecule Protein Reading Using ClpX Unfoldase and CsgG Nanopore Published in Nature
Sep 11, 2024, 04:19 PM
A groundbreaking approach for single-molecule protein reading has been published in Nature. The technique utilizes ClpX unfoldase to ratchet proteins through a CsgG nanopore, achieving single-amino-acid sensitivity. This advancement, described by researchers including Jeff Nivala and the team from ONT, represents a significant leap in protein sequencing technology. The method allows for multi-pass, single-molecule reading of long protein strands, and can detect post-translational modifications. It requires chemical conjugation of functional amino acids. This development is expected to have profound implications for biological research and understanding protein structures.
View original story
Similar markets
Illumina • 25%
Thermo Fisher Scientific • 25%
Bio-Rad Laboratories • 25%
Other • 25%
Yes • 50%
No • 50%
Amgen • 25%
Genentech • 25%
Regeneron • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Pfizer • 25%
Moderna • 25%
Novartis • 25%
Other • 25%
